Engineering chimeric antigen receptor T cell signals to generate effective anti-tumour responses
Grant award · Australia · Last reported Dec 2018
Source: GrantConnect
Immunotherapy using genetically engineered killer cells, redirected towards a patients tumour, has revolutionised the way we treat cancer. While these treatments have been very effective, they are not without side effects. This study will enable the design of tailored and safe immunotherapy treatments so that immune responses can be tailored to the tumour type. This research will help design bette
- Status
- Prospective
- Sector
- Hospital, Government
- Location
- Australia
- Updated
- 19 Nov 2026
- Source
- GrantConnect
ConstructChat
Ask ConstructChat about Engineering chimeric antigen receptor T cell signals to generate effective anti-tumour responses
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | grant award |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Immunotherapy using genetically engineered killer cells, redirected towards a patients tumour, has revolutionised the way we treat cancer. While these treatments have been very effective, they are not without side effects. This study will enable the design of tailored and safe immunotherapy treatments so that immune responses can be tailored to the tumour type. This research will help design better therapies for cancer patients. |
Original sector | Medical Research |
Budget |
Location
Country | Australia |
Source
Source | GrantConnect |
URL |
More Details
Record type | Project |
Sector | Hospital, Government |
Article published date | 2024-12-16 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
